Search the Newsreel

Central Garden & Pet Co (CENT) (Q3 2026) Earnings Call Highlights: Organic Growth and ...

This article first appeared on GuruFocus. Net Sales: Declined 8% to $882 million, impacted by the exit of the Pet distribution business. Organic Net Sales: Rose 2% to $862 million, reflecting growth in both Garden and Pet segments. Non-GAAP Gross Profit: $318 million, down …

Central Garden & Pet Company A (CENTA) shows split momentum before results

The consumer defensive stock has cooled in recent weekly returns, even as the longer lookback remains positive before earnings.

Earnings call transcript: Central Garden & Pet lifts Q3 2026 outlook

Key Points Interested in Central Garden & Pet Company? Here are five stocks we like better. Central Garden & Pet raised its fiscal 2026 adjusted EPS outlook to $2.85 or better from $2.70, despite reported third-quarter sales falling 8% to $882 million following its …

Central Garden & Pet (NASDAQ:CENTA) Releases FY 2026 Earnings Guidance

Central Garden & Pet (NASDAQ:CENTA) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Central Garden (CENT) Surpasses Q3 Earnings and Revenue Estimates

Central Garden (CENT) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.56 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Central Garden (CENTA) Tops Q3 Earnings and Revenue Estimates

Central Garden & Pet (NASDAQ:CENT) Exceeds Q2 CY2026 Expectations

Central Garden & Pet (NASDAQ:CENT) Exceeds Q2 CY2026 Expectations Pet company Central Garden & Pet (NASDAQ:CENT) reported Q2 CY2026 results exceeding the market's revenue expectations , but sales fell by 8.2% year on year to $882.4 million. Its non-GAAP profit of $1.54 per share …

Earnings Flash (CENT) Central Garden & Pet Company Reports Q3 Revenue $882.4M, vs. FactSet Est of $883.0M

Central Garden & Pet Company (CENT) reported its Q3 revenue at $882.4 million, slightly below FactSet's estimate of $883.0 million. This financial update follows another recent announcement where the company posted adjusted EPS of $1.54 per share, surpassing FactSet's estimate of $1.53. The company …

Central Garden & Pet Announces Q3 Fiscal 2026 Financial Results

Central Garden & Pet announced its Q3 fiscal 2026 financial results, showing continued strength with improved organic sales and margins. The company raised its fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better and disclosed a definitive agreement to acquire an 80% interest …

Central Garden & Pet earnings on deck amid revenue headwinds By Investing.com

Central Garden & Pet is set to report its fiscal third-quarter earnings with analysts expecting an EPS of $1.51 on revenue of $895.77 million. Despite anticipated sequential EPS growth, revenue is forecast to decline, raising investor focus on the company's ability to maintain profitability …

Ascentage Pharma (AAPG) sets August 19 board meeting on results

Ascentage Pharma Group International (AAPG) has announced a board meeting scheduled for August 19, 2026. The main purpose of this meeting is to review and approve the company's unaudited interim results for the six months ending June 30, 2026, and to authorize their publication. …

CORRECTION: Ascentage Pharma to Report 2026 Six Month

Ascentage Pharma Group International has issued a correction regarding the timing of its 2026 Six Month Interim Results announcement and corporate update. The event will now take place at 7:00 am Eastern Daylight Time (EDT) on August 19, 2026, with an English language webcast …

Ascentage Pharma Schedules Chinese and English Webcasts Aug. 19-20

Ascentage Pharma announced it will release its unaudited six-month 2026 interim results and provide a corporate update on August 19, 2026, at 7:00 am EDT / 7:00 pm HKT. The company will host a Mandarin investor webcast on August 19, 2026, and an English …

Central Garden & Pet Company 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:CENT) 2026-08-05

First Trust Advisors LP Purchases 31,009 Shares of Central Garden & Pet Company $CENTA

Central Garden & Pet (CENTA) Earnings Date and Reports 2026

(CENTA) and the Role of Price-Sensitive Allocations

This article analyzes Central Garden & Pet Company Class A Common Stock Nonvoting (NASDAQ: CENTA), highlighting weak near-term sentiment despite potential long-term strength. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis also includes multi-timeframe …

Ascentage Pharma (NASDAQ: AAPG) names new CBO and CCO for global growth

Ascentage Pharma Group International has appointed Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer to bolster its global expansion strategy. Dr. Miyara will lead global business development, while Mr. Ziegler will manage commercialization in the United States and …

Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.6% - Here's Why

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Ascentage Pharma has announced the appointments of Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer. These appointments aim to strengthen the company's global business development and establish a dedicated commercial organization in the United States. Both executives will …

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Average Rating of "Buy" from Analysts

Ascentage Pharma Group Number of Employees 2026 | Employee Count & Headcount Data

Ascentage Pharma Group International Co., Ltd. (6855) has approximately 760 employees worldwide as of March 2026, marking a 19.2% growth since 2023. The company, headquartered in Suzhou, China, with major operations in China and the United States, is actively hiring, with 5 active job …

Ascentage Pharma Group International Revenue Breakdown – HKEX:6855

Ascentage Pharma Group International (HKEX:6855) generated 638.92 million HKD last year, with its top-performing segment, Therapies for Hematological Malignancies, contributing 541.47 million HKD. The majority of this revenue, 622.65 million HKD, came from China. The article provides a breakdown of the company's revenue by …

Lazard Asset Management LLC Buys 49,201 Shares of Central Garden & Pet Company $CENTA

Ascentage Pharma (NASDAQ: AAPG) CEO ranks No.3 on Medicine Maker 2026 list

Ascentage Pharma's Chairman and CEO, Dr. Dajun Yang, has been recognized on The Medicine Maker Power List 2026, ranking No. 3 in the Small Molecules category. The list honors 60 global leaders driving innovation in drug discovery and development. Dr. Yang's inclusion highlights his …

Central Garden & Pet Company Revenue Breakdown – NASDAQ:CENT

Central Garden & Pet to Participate in Investor Conferences

WALNUT CREEK, Calif., July 30, 2026--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading consumer goods company in the pet and garden industries, today announced that it will participate in the following upcoming investor conferences: CG 46th Annual Growth Conference (August …

Central Garden & Pet (CENTA) Q2 2026 Earnings: Strong EPS Beat Despite Flat Revenue; Shares Dip on Caution

Is Sky Metals (ASX:SKY) Stock Worth Considering After Its Tallebung Resource Upgrade?

Why Investors Are Watching Centaurus Metals (ASX:CTM) Stock as Jaguar Nickel Nears a Final Decision

Ascentage Pharma Group International (AAPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ascentage Pharma Group International (AAPG), covering key indicators and moving averages. It details the current signals for MACD, RSI, KDJ, and others, showing a mix of neutral and sell signals, alongside various moving average values. The analysis …

Central Garden & Pet (CENT) Expected to Announce Earnings on Wednesday

Central Garden & Pet (CENTA) Projected to Post Quarterly Earnings on Wednesday

Central Garden & Pet (CENT) As The TRIXIE Deal Puts Its Valuation Back In Focus

CEO and CFO to lead Central Garden & Pet's Aug. 5 results call

Central Garden & Pet Company (NASDAQ: CENT, NASDAQ: CENTA) announced it will release its fiscal 2026 third-quarter financial results after market close on Wednesday, August 5, 2026. Following the release, the company will host a conference call at 4:30 p.m. ET (1:30 p.m. PT) …